<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="utf-8">
  <meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
  <title>Meta-Analysis of Preclinical Studies of Fibrinolytic Therapy for Acute Lung Injury - VetSRev</title>
  <link rel="stylesheet" href="/vendor/bootstrap-4.3.1.min.css">
  <link rel="stylesheet" href="/vendor/fontawesome-5.8.1.min.css">

  <link rel="preconnect" href="https://fonts.googleapis.com">
  <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
  <link href="https://fonts.googleapis.com/css2?family=Roboto:ital,wght@0,100;0,300;0,400;0,700;1,400&display=swap" rel="stylesheet">

  <link rel="stylesheet" href="/assets/style.css" media="screen" type="text/css">

  <link rel="apple-touch-icon" sizes="180x180" href="/apple-touch-icon.png">
  <link rel="icon" type="image/png" sizes="32x32" href="/favicon-32x32.png">
  <link rel="icon" type="image/png" sizes="16x16" href="/favicon-16x16.png">
  <link rel="manifest" href="/site.webmanifest">
</head>

<body>
  <!-- HEADER -->
  <div class="header">
    <div class="container">
      <img src="/assets/CEVMLogo.png" alt="logo"/>
      <div class="title">
        <h1>VetSRev</h1>
        <p class="hidden-xs">Database of veterinary systematic reviews</p>
      </div>
    </div>
  </div>

  <!-- Navigation -->
  <div class="container">
    <nav class="navbar navbar-expand navbar-light bg-light">
      <button class="navbar-toggler" type="button" data-toggle="collapse" data-target="#navbarSupportedContent" aria-controls="navbarSupportedContent" aria-expanded="false" aria-label="Toggle navigation">
        <span class="navbar-toggler-icon"></span>
      </button>

      <div class="collapse navbar-collapse" id="navbarSupportedContent">
        <ul class="navbar-nav mr-auto">
          <li class="nav-item"><a class="nav-link" href="/">Home</a></li>
          <li class="nav-item"><a class="nav-link" href="/about.html">About the database</a></li>
        </ul>
      </div>
    </nav>
  </div>

  <!-- CONTENT -->
  <div class="container">
  <div class="publication">
  <h1>Meta-Analysis of Preclinical Studies of Fibrinolytic Therapy for Acute Lung Injury</h1>
  <h2>Liu, C. and Ma, Y. and Su, Z. and Zhao, R. and Zhao, X. and Nie, H. G. and Xu, P. and Zhu, L. and Zhang, M. and Li, X. and Zhang, X. and Matthay, M. A. and Ji, H. L.</h2>

  
  <p>Front Immunol (2018) 9: 1898</p>
  

  
  <p>DOI: <a href="https://doi.org/10.3389/fimmu.2018.01898">10.3389/fimmu.2018.01898</a></p>
  

  
  <h2>Abstract</h2>
  <p>BACKGROUND: Acute lung injury (ALI) is characterized by suppressed fibrinolytic activity in bronchoalveolar lavage fluid (BALF) attributed to elevated plasminogen activator inhibitor-1 (PAI-1). Restoring pulmonary fibrinolysis by delivering tissue-type plasminogen activator (tPA), urokinase plasminogen activator (uPA), and plasmin could be a promising approach. OBJECTIVES: To systematically analyze the overall benefit of fibrinolytic therapy for ALI reported in preclinical studies. METHODS: We searched PubMed, Embase, Web of Science, and CNKI Chinese databases, and analyzed data retrieved from 22 studies for the beneficial effects of fibrinolytics on animal models of ALI. RESULTS: Both large and small animals were used with five routes for delivering tPA, uPA, and plasmin. Fibrinolytics significantly increased the fibrinolytic activity both in the plasma and BALF. Fibrin degradation products in BALF had a net increase of 408.41 ng/ml vs controls (P \textless 0.00001). In addition, plasma thrombin-antithrombin complexes increased 1.59 ng/ml over controls (P = 0.0001). In sharp contrast, PAI-1 level in BALF decreased 21.44 ng/ml compared with controls (P \textless 0.00001). Arterial oxygen tension was improved by a net increase of 15.16 mmHg, while carbon dioxide pressure was significantly reduced (11.66 mmHg, P = 0.0001 vs controls). Additionally, fibrinolytics improved lung function and alleviated inflammation response: the lung wet/dry ratio was decreased 1.49 (P \textless 0.0001 vs controls), lung injury score was reduced 1.83 (P \textless 0.00001 vs controls), and BALF neutrophils were lesser (3 × 10(4)/ml, P \textless 0.00001 vs controls). The mortality decreased significantly within defined study periods (6 h to 30 days for mortality), as the risk ratio of death was 0.2-fold of controls (P = 0.0008). CONCLUSION: We conclude that fibrinolytic therapy may be effective pharmaceutic strategy for ALI in animal models.</p>
  

  <h2>Citation</h2>
  <p class="citation"><span id="liu_meta-analysis_2018">Liu, C., Ma, Y., Su, Z., Zhao, R., Zhao, X., Nie, H. G., Xu, P., Zhu, L., Zhang, M., Li, X., Zhang, X., Matthay, M. A., &amp; Ji, H. L. (2018). Meta-Analysis of Preclinical Studies of Fibrinolytic Therapy for Acute Lung Injury. <i>Front Immunol</i>, <i>9</i>, 1898. https://doi.org/10.3389/fimmu.2018.01898 <b>Animals, Humans, Mice, Disease Models, Animal, Drug Evaluation, Preclinical, Odds Ratio, Mortality, *fibrinolytic agents, *interventions, *lung diseases, *molecular therapy, *preclinical study, *Thrombolytic Therapy, Acute Lung Injury/*drug therapy/etiology/metabolism/mortality, Fibrinolytic Agents/pharmacology/*therapeutic use, Neutrophils/immunology/metabolism</b></span> </p>


  <h2>Keywords</h2>
  <ul>
    
    
      <li>Animals</li>
    
      <li>Humans</li>
    
      <li>Mice</li>
    
      <li>Disease Models</li>
    
      <li>Animal</li>
    
      <li>Drug Evaluation</li>
    
      <li>Preclinical</li>
    
      <li>Odds Ratio</li>
    
      <li>Mortality</li>
    
      <li>*fibrinolytic agents</li>
    
      <li>*interventions</li>
    
      <li>*lung diseases</li>
    
      <li>*molecular therapy</li>
    
      <li>*preclinical study</li>
    
      <li>*Thrombolytic Therapy</li>
    
      <li>Acute Lung Injury/*drug therapy/etiology/metabolism/mortality</li>
    
      <li>Fibrinolytic Agents/pharmacology/*therapeutic use</li>
    
      <li>Neutrophils/immunology/metabolism</li>
    
  </ul>

</div>

  </div>

  <!-- FOOTER -->
  <div class="container">
    <div class="footer">


      <h3>VetSRev</h3>
      <p class="strap">Database of veterinary systematic reviews</p>

      <p>To cite this resource please use the following:</br>
      Veterinary Systematic Review database (2021) VetSRev database (Version 2.0). Available at: https://vetsrev.nottingham.ac.uk.</p>


      <p class="smallprint"><a href="/cookies.html">Cookies policy</a></p>

    </div>
  </div>

  <!-- Cookie-Alert -->
  <div class="alert alert-dark alert-dismissible cookiealert" role="alert">

    We'd like to set some analytics cookies to help us improve our website.

    <a href="/cookies/">Learn more.</a>
    <button type="button" class="btn btn-outline-secondary btn-sm declinecookies" data-dismiss="alert">Decline</button>
    <button type="button" class="btn btn-primary btn-sm acceptcookies">Accept</button>

    <button type="button" class="close" data-dismiss="alert" aria-label="Close">
      <span aria-hidden="true">&times;</span>
    </button>
  </div>


  <!-- jQuery first, then Popper.js, then Bootstrap JS -->
  <script src="/vendor/jquery-3.5.1.min.js"></script>
  <script src="/vendor/popper.min.js "></script>
  <script src="/vendor/bootstrap-4.3.1.min.js "></script>

  


  


  <!-- cookies and Google Analytics-->
  <script src="/assets/cookies.js "></script>

</body>
</html>
